IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q4 2012 Holdings

Filed 2013-10-04 | 3 holdings | $232.7K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Synta Pharmaceuticals CorpCOM87162T206$185.2K20,527,27779.6%
Vivus IncCOM928551100$38.1K2,838,00016.4%
Hallmark Finl Svcs Inc ECCOM NEW40624Q203$9.4K1,005,9814.1%